Related Experiment Videos
Using immunotherapy to target EGF in patients with NSCLC
Deirdre O'Mahony1, Phillip A Dennis
1Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20889, USA.
Cancer Biology & Therapy
|March 23, 2006
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Oncology Medical Homes: ASCO-Community Oncology Alliance Standards.
JCO oncology practice·2025
Elevating Cancer Care Standards Worldwide: An Analysis of Global Initiatives and Progress.
JCO global oncology·2024
ASCO Domestic Quality Programs.
JCO global oncology·2024
Impact of Medical Oncology-Focused Quality Programs on Cancer Care Around the World.
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2024
DNA polymerase theta (Polθ): a novel candidate for targeted cancer therapy.
Cancer biology & therapy·2026
Targeting molecular and genetic pathways driving tumorigenesis for precision therapy in colorectal cancer.
Cancer biology & therapy·2026
Bis-(di-4-phenyl-benzylaminethiocarbonyl)disulfide sensitizes ABCC2/ALDH3A1 overexpressing NSCLC cells to cisplatin.
Cancer biology & therapy·2026
Mechanisms of antibody-mediated enhancement of immune responses.
The Journal of experimental medicine·2026
A predictive multiscale framework for post-translational modification-dependent peptide-MHC class I binding.
Physical chemistry chemical physics : PCCP·2026
Persistently Elevated Serum IgM: A Diagnostic Red Flag for Primary Immunodeficiencies: A Case-Based Review and Clinical Approach.
Endocrine, metabolic & immune disorders drug targets·2026
Extended routine lymphocyte immunophenotyping refines individual immune organization across a heterogeneous patient cohort.
Cytometry. Part B, Clinical cytometry·2026
Lung ultrasound and the interstitial syndrome in tuberculosis endemic regions: illustrated insights from diverse clinical settings.
Journal of clinical tuberculosis and other mycobacterial diseases·2026